Gentize Biopharma

Gentize Biopharma, a clinical-stage vaccine developer based in Nanjing, has reportedly raised close to RMB 100 million (USD 13.64 million) in a Pre-Series A financing round. The round was solely funded by Hyfinity Investments, highlighting the investor’s confidence in Gentize’s innovative vaccine portfolio. Financing and Future PlansThe proceeds from this…